CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale 10% owner sold 322,361 shares at an average $0.19 ($61,206)
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 220,255 shares at an average $0.19 ($41,184)
- 4 Open-market sale 10% owner sold 349,764 shares at an average $0.20 ($71,097)
- 4 Open-market sale 10% owner sold 1,379,119 shares at an average $0.23 ($315,262)
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Delisting notice
- 4 Open-market buy Chief Medical Officer bought 305,000 shares at an average $0.26 ($78,825)
- 4 Open-market buy SVP Finance, CFO bought 17,500 shares at $0.25 ($4,335)
Page 9 of 34 · 678 filings